Euthyroid sick syndrome medical therapy: Difference between revisions
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) |
||
Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
In euthyroid sick syndrome emphasis is on rapid correction of underlying disease. Many seriously ill patients have low levels of thyroid hormones but are not clinically hypothyroid and do not require thyroid hormone supplementation. Replacement of thyroid hormones in euthyroid sick syndrome is controversial except, in patients of congestive heart failure where liothyronine (LT3) or levothyroxine (LT4) may be recommended, to improve ventricular performance. Therefore, thyroid hormone therapy is generally not recommended for patients with euthyroid sick syndrome, except possibly those with chronic heart failure.<ref name="PingitoreLandi2005">{{citejournal|last1=Pingitore|first1=Alessandro|last2=Landi|first2=Patrizia|last3=Taddei|first3=Maria Chiara|last4=Ripoli|first4=Andrea|last5=L’Abbate|first5=Antonio|last6=Iervasi|first6=Giorgio|title=Triiodothyronine levels for risk stratification of patients with chronic heart failure|journal=The American Journal of Medicine|volume=118|issue=2|year=2005|pages=132–136|issn=00029343|doi=10.1016/j.amjmed.2004.07.052}}</ref> | In euthyroid sick syndrome emphasis is on rapid correction of underlying disease. Many seriously ill patients have low levels of thyroid hormones but are not clinically hypothyroid and do not require thyroid hormone supplementation. Replacement of thyroid hormones in euthyroid sick syndrome is controversial except, in patients of congestive heart failure where liothyronine (LT3) or levothyroxine (LT4) may be recommended, to improve ventricular performance. Therefore, thyroid hormone therapy is generally not recommended for patients with euthyroid sick syndrome, except possibly those with chronic heart failure.<ref name="PingitoreLandi2005">{{citejournal|last1=Pingitore|first1=Alessandro|last2=Landi|first2=Patrizia|last3=Taddei|first3=Maria Chiara|last4=Ripoli|first4=Andrea|last5=L’Abbate|first5=Antonio|last6=Iervasi|first6=Giorgio|title=Triiodothyronine levels for risk stratification of patients with chronic heart failure|journal=The American Journal of Medicine|volume=118|issue=2|year=2005|pages=132–136|issn=00029343|doi=10.1016/j.amjmed.2004.07.052}}</ref><ref name="pmid7140337">{{cite journal |vauthors=Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH, McManus WF, Pruitt BA, Mason AD |title=Hypermetabolic low triiodothyronine syndrome of burn injury |journal=Crit. Care Med. |volume=10 |issue=12 |pages=870–5 |year=1982 |pmid=7140337 |doi= |url=}}</ref> | ||
==References== | ==References== |
Revision as of 16:27, 9 August 2017
Euthyroid sick syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Euthyroid sick syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Euthyroid sick syndrome medical therapy |
Risk calculators and risk factors for Euthyroid sick syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Medical Therapy
In euthyroid sick syndrome emphasis is on rapid correction of underlying disease. Many seriously ill patients have low levels of thyroid hormones but are not clinically hypothyroid and do not require thyroid hormone supplementation. Replacement of thyroid hormones in euthyroid sick syndrome is controversial except, in patients of congestive heart failure where liothyronine (LT3) or levothyroxine (LT4) may be recommended, to improve ventricular performance. Therefore, thyroid hormone therapy is generally not recommended for patients with euthyroid sick syndrome, except possibly those with chronic heart failure.[1][2]
References
- ↑ Template:Citejournal
- ↑ Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH, McManus WF, Pruitt BA, Mason AD (1982). "Hypermetabolic low triiodothyronine syndrome of burn injury". Crit. Care Med. 10 (12): 870–5. PMID 7140337.